Abstract
Formins are actin polymerization factors that elongate unbranched actin filaments at the barbed end. Rho family GTPases activate Diaphanous-related formins through the relief of an autoregulatory interaction. The crystal structures of the N-terminal domains of human FMNL1 and FMNL2 in complex with active Cdc42 show that Cdc42 mediates contacts with all five armadillo repeats of the formin with specific interactions formed by the Rho-GTPase insert helix. Mutation of three residues within Rac1 results in a gain-of-function mutation for FMNL2 binding and reconstitution of the Cdc42 phenotype in vivo. Dimerization of FMNL1 through a parallel coiled coil segment leads to formation of an umbrella-shaped structure that—together with Cdc42—spans more than 15 nm in diameter. The two interacting FMNL–Cdc42 heterodimers expose six membrane interaction motifs on a convex protein surface, the assembly of which may facilitate actin filament elongation at the leading edge of lamellipodia and filopodia.
Similar content being viewed by others
Introduction
The actin cytoskeleton is a highly dynamic structure that regulates cell shape and motility. The assembly of globular actin molecules into actin filaments (F-actin) is spatially and temporally controlled by nucleation and elongation factors. Among these, the multidomain proteins of the formin family regulate a variety of distinct F-actin structures in vertebrates, such as stress fibres, filopodia, lamellipodia or cell adhesions1,2,3. Formins thus influence a large number of major cellular processes like cell migration, polarity and cell cycle progression. The 15 mammalian formins that are defined by the presence of formin homology (FH) domains cluster into 8 different families based on their domain architectures4.
The actin polymerization activity of formins is mediated by the FH2 domain that resembles an anti-parallel, torus-shaped dimer, which remains associated with the F-actin barbed end on elongation5,6. The FH2 domain is preceded by a proline-rich FH1 domain that interacts with profilin-actin and accelerates the elongation rate of actin filaments7,8. For some formins, the region C-terminal to the FH2 domain may additionally contribute to actin polymerization kinetics9,10,11. Besides regulating elongation, formins possess actin nucleation12,13,14, filament bundling15 and presumably severing11 activity. The activity of some formins is regulated by an N- to C-terminal intramolecular interaction that renders the protein inactive, giving rise to the classification as Diaphanous-related formins (DRFs). In DRFs, the N-terminal regulatory domains comprise a GTPase-binding domain (GBD) followed by an FH3 domain that interacts with the C-terminal Diaphanous-autoregulatory domain (DAD). The inhibition is released on binding of an active Rho-GTPase to the formin GBD16,17,18. With the exception of FHOD, all mammalian DRFs also harbour a dimerization element C-terminal to the FH3 domain, constituting a second seed for the overall assembly of these proteins into multimers.
Rho family GTPases cycle between an inactive, GDP-bound state and an active, GTP-bound state19. In the active state, they have been shown to regulate cellular signalling by binding to a large variety of downstream effectors linking extracellular stimuli to actin cytoskeleton rearrangements20. Activation of the autoinhibited formin is supposed to occur on displacement of the autoregulatory DAD by the GTPase17,18,21. However, additional signals such as phosphorylation of the DAD or other DAD-interacting factors may also stabilize the active conformation of the DRF22.
The mammalian formin-like proteins constitute one family of DRFs, which include the large, multidomain proteins FMNL1, FMNL2 and FMNL3 (also known as FRL1 or formin-related gene in leucocytes, FRL3/FHOD2 and FRL2/FHOD3, respectively)23. An actin filament polymerization and bundling activity of FMNL formins have been described24,25,26,27,28; in addition, FMNL1 appears to sever actin filaments24. The misregulation of FMNL proteins has been shown to cause various tumours, such as chronic lymphatic leukaemia or non-Hodgkin's lymphoma29,30, but also colorectal carcinoma31 and breast carcinoma32. In agreement with this, the macrophage-enriched FMNL1 has been reported to be involved in cell adhesion, migration and survival23. FMNL1 has furthermore been reported to be an essential regulator of centrosome polarity33, to exhibit crucial functions in the cytotoxic activation of T cells33 and to be required for Fcγ receptor-induced phagocytosis34. FMNL2 contributes to the formation of protrusive actin structures such as lamellipodia and filopodia at the leading edge of migrating cells28,35. Consistently, overexpression of this protein appears to cause metastasis of tumour cells31,36. Furthermore, depletion of FMNL2 has been implicated in developmental disorders like mental retardation, premature onset of puberty and limb abnormalities37.
To date, it remains unclear how FMNL formins are activated and how the specificity of GTPases for formin effectors is determined. Several Rho GTPases such as RhoC, Rac1 and Cdc42 have been implicated in the activation of FMNL1 and FMNL2 (refs 23, 28, 32, 33, 34, 38, 39, 40). Aside from interacting with Rho GTPases, membrane targeting mechanisms emerged as an important feature of formins, as the actin-based protrusions are confined to distinct cellular compartments. We have previously shown that Cdc42 recruits full-length FMNL2 into lamellipodia and filopodia28. Here we uncover the structural basis of the specificity of FMNL1 and FMNL2 binding towards Cdc42, its membrane association, as well as the dimerization properties of the formin. We find that the insert helix of Cdc42 contributes essential interactions to the formin effector and that the protein complex forms a convex membrane interaction site to promote filopodia and lamellipodia outgrowth.
Results
Overall structure of the Cdc42–FMNL2N complex
To explore the activating complex between Cdc42 and FMNL2, we solved the X-ray crystal structure of the GBD-FH3 domains of human FMNL2 (amino acids (aa) 1–379, termed FMNL2N) with Cdc42 (1–179) bound to the non-hydrolyzing nucleotide analogue GppNHp (Fig. 1a,b). The structure was determined to 2.5 Å resolution; the asymmetric unit of the crystal contained one heterodimer and the structure model was refined to an Rwork of 19.4% and Rfree of 25.3% with excellent stereochemistry (Table 1). Compared with the published structure of mDia1N bound to Cdc42 (ref. 21), the FMNL2N–Cdc42GppNHp structure shows remarkable differences in the interaction of the GTPase with the armadillo repeat helices of the formin. The buried molecular surface area of 3,034 Å2 counting both molecules FMNL2N and Cdc42 is 51% larger than that of mDia1N–Cdc42. This increase in interaction surface is mostly due to additional contacts formed between the Cdc42 insert helix and the fourth and fifth armadillo repeat of the FH3 domain.
The FH3 domain of FMNL2 is composed of 14 canonical helices that assemble into 5 armadillo repeats with the first 2 helices resembling a heat repeat fold. This leads to formation of a combined surface of five long helixes at the concave site of the curved armadillo repeat structure. Two non-canonical helices (α5 and α9) are located before the long helices of the first two repeats (Fig. 1b). Both helices are kinked by ∼60° from the concave surface of the armadillo repeat. A loop sequence of 55 residues (150–204) that is not resolved in the crystal structure precedes the second helix of this non-canonical element. The N-terminal three helices (33–69) of the GBD are arranged similarly as seen in the mDia1N–RhoC complex17 with the connecting linker sequence (70–76) to the armadillo repeat domain being fully resolved in our crystal structure. Multiple hydrophobic and polar contacts are formed between the switch regions of Cdc42 and the armadillo repeats of FMNL2. Particularly, V36 and F37 of switch I and L67 and L70 of switch II of the GTPase contribute with hydrophobic interactions to the GBD of the formin (Supplementary Fig. 1a). Salt bridges and polar interactions are formed between E62, D63, D65 and R66 of switch II that reach out up to the second armadillo repeat of the FMNL2 effector domain (Supplementary Fig. 1b).
Cdc42 interacts with all armadillo repeats of FMNL2
Strikingly, residues of all five armadillo repeats of the FMNL2 FH3 domain participate in Cdc42 binding and contribute to the specificity of the interaction. A network of polar hydrogen bonds, whose alternating charges resemble a kind of electrostatic zipper, recurs throughout the beginning of the long armadillo repeat helices of FMNL2 (Fig. 1c,d). These residues mediate interactions with the switch II helix of Cdc42, the characteristic α3-helix and the Rho-GTPase-specific insert helix of Cdc42. Rho GTPases contain an insert of about 12 residues that forms the exposed 'insert helix' α4 and distinguishes this GTPase family from all other Ras-like GTPases (Supplementary Fig. 2). A superimposition of the FH3 domains of FMNL2 and mDia1 shows that helices α3 and α4 of Cdc42 are coming significantly closer to the armadillo repeat structure of FMNL2 compared with the mDia1N–Cdc42 complex structure (Supplementary Fig. 3a), yielding additional interactions between the two subunits. An interaction scheme displaying the contacts between FMNL2 and Cdc42 within a distance shell of 3.7 Å is shown in Fig. 2.
Cdc42, Rac1 to -3 and RhoA to -C all contain a conserved proline residue in the α3-helix that aligns to position 99 of Cdc42 (Supplementary Fig. 2b). The presence of this proline within a helix leads to formation of a characteristic bulge four residues upstream, likely due to the missing ability to form a hydrogen bond within the helical backbone (Fig. 1c). This results in exposure of E95 in Cdc42, which is characteristic for Rho GTPases and observed also in the absence of an effector protein. On complex formation with FMNL2, the carboxyl groups of E95 mediate salt bridges with H222 and R261 of the formin, thus coordinating two armadillo repeats of the effector protein (Fig. 1c). This specific interaction shown in a stereo display of the electron density map (Supplementary Fig. 3b) is only possible because of the exposed position of the glutamate in the helical bulge of the GTPase.
Second, a KNK motif at the tip of the Rho-GTPase-specific insert helix participates in the interaction with FMNL2. Polar interactions and a salt bridge are formed between the amino groups of the two lysines K133 and K131 in Cdc42 with acidic residues E311 and D360 of the fourth and fifth armadillo repeat of FMNL2, respectively. The interaction is sustained by a hydrogen bond between N132 and S361 (Fig. 1d). To our knowledge, this is the first observation of an effector-specific interaction of the Rho-GTPase insert helix with an effector protein. While residues in the switch I and switch II regions are rather well conserved in the Rho-GTPase family, compared, for example, with the Ras superfamily, it is the insert helix that exhibits higher sequence variability and can thus contribute to the specificity of the GTPase–effector interaction (Fig. 1d).
The interactions of Cdc42 with the N-terminal GBD of FMNL2 are largely of hydrophobic nature and overall similar to the binding observed in the mDia1N–RhoC complex formation17. A previously unseen interaction is formed between K73 in the linker connecting the GBD with the armadillo repeats of FMNL2 with the backbone oxygen of H103 in Cdc42 (Fig. 1c). The three helices of the GBD appear flexible and not well coordinated in the absence of the GTPase, a feature that classifies the GBD as a subdomain rather than a full domain entity.
A Rac1 gain-of-function mutation for FMNL2 binding
To examine the contribution of the Rho-GTPase-specific insert helix for FMNL2 binding, we aimed at generating a Rac1 gain-of-function mutation for the interaction with the formin effector protein. We analysed the binding of Cdc42GppNHp to FMNL2N by isothermal titration calorimetry (ITC) and determined a dissociation constant of 1.9 μM, whereas no interaction was seen for either Rac1 or RhoA binding (Table 2 and ref. 28). Proteomic analyses identified a phosphorylation site for S171 (ref. 41), which is in the centre of the flexible loop preceding helix α9 (Supplementary Fig. 4) and not resolved in the crystal structure. We introduced two aspartates at the site of S171 as a mimic of a negatively charged phosphorylation group. Using this S171DD mutant protein, the affinity of Cdc42GppNHp for FMNL2N was further improved to 0.79 μM, possibly due to increased protein stability and solubility in course of the ITC measurement.
The interaction map of FMNL2 binding in the complex interface with the GTPase reveals only three residues difference between Cdc42 and Rac1 (Fig. 2). We first mutated A95 in Rac1 to glutamate to allow formation of the hydrogen bond network with H222 and R261 of FMNL2 (Fig. 3a, left panel). ITC experiments, however, showed no binding, suggesting that exchange of the alanine to glutamate was not sufficient to increase the affinity to detection levels (Fig. 3b). Next, the two residues E131 and K132 in the insert helix of Rac1 were exchanged to its Cdc42 counterparts K131 and N132, respectively, introducing thereby a charge reversal for the proposed interaction with E360 of FMNL2 (Fig. 3a, right panel). The affinity of this Rac1 (E131K and K132N) double mutant increased indeed to 10.6 μM as determined by ITC (Fig. 3c). Combining all three mutations, A95E, E131K and K132N, finally raised the affinity of this Rac1 triple mutant for FMNL2 binding to 0.9 μM (Fig. 3d), exhibiting now the same affinity as the cellular activator Cdc42 (Table 2). We thus generated a gain-of-function mutation of Rac1 for FMNL2 binding by exchanging only three residues in the GTPase, of which two are in the insert helix and none in the switch regions. A minor contribution to the specificity of the interaction might come as well from K94 in Cdc42, which represents an arginine in Rac1-3 and a proline in RhoA-C. This residue can form a salt bridge with D219 of FMNL2, although the electron density is not well resolved in the crystal structure.
To test in cells whether the triple mutant was capable of interacting with and activating FMNL2, we analysed the localization of an autoinhibited, enhanced green fluorescent protein (EGFP)-labelled variant of FMNL2 (ref. 28) in the presence of Cdc42, Rac1 or the Rac1 triple mutant (Fig. 3e). In the absence of a transfected Rho-GTPase, wild-type FMNL2 tagged at the N terminus with EGFP was entirely cytosolic in B16-F1 cells28. As shown previously, co-expression of this FMNL2 variant with constitutively active Cdc42 (Q61L mutant) directed the formin to the cell periphery (Fig. 3e and ref. 28). Such effect was not observed for constitutively active Rac1 (Rac1 L61), in spite of prominent induction of lamellipodia, whereas co-expression of Rac1 L61 triple mutant (A95E, E191K and K192N) caused prominent accumulation of EGFP–FMNL2 at the cell periphery (Fig. 3e). These data demonstrate that Rac can be functionalized to activate FMNL2 in vivo solely through enabling its interaction with the formin. Interestingly, this specificity is underscored by the finding that the Rac triple mutant maintained the capability of interacting with the WAVE complex, but was still unable to bind to the Cdc42-effector N-WASP (Supplementary Fig. 5).
Myristoylation and a basic patch mediate membrane binding
The neighbouring helices α5 and α9 interrupting the canonical armadillo repeat fold contain two basic patches composed of six positively charged residues each (Fig. 4a). The sequence motifs 93RKKFRRR on the first and 206RRTLKNSRLVSKK on the second helix assemble in a way that all 12 basic moieties are exposed on the surface of FMNL2 at a position adjacent to the Cdc42 binding site (Fig. 4b). Together, these residues constitute a strongly positively charged patch as seen from the electrostatic surface representation (Fig. 4c). The basic sequence is conserved in all three mammalian FMNL homologues, with 10 and 11 positively charged residues in FMNL1 and FMNL3, respectively (Supplementary Fig. 4). The flexible loop of 55 residues that is not resolved in the electron density map of the FMNL2N–Cdc42 structure is directly preceding the second basic helix α9. Interestingly, this loop is missing in one splice variant of FMNL3, isoform 2, but otherwise conserved in all FMNLs (Supplementary Fig. 4).
As FMNL2 is myristoylated and likely activated by membrane-associated Cdc42, we analysed the contribution of these two membrane targeting motifs for localization of the formin at the plasma membrane. Fluorescent mEGFP was fused C-terminally to FMNL2N 1–385, such that the N-terminal MGxxxS motif of FMNL2 is accessible for co-translational myristoylation in cells. Expression plasmids were transfected into B16-F1 melanoma cells and only cells with a weak protein expression level were considered for evaluation. Relative membrane association of each construct was determined by two alternative methods, revealing highly similar results (Fig. 5 and Supplementary Fig. 6). Wild-type FMNL2N and the phosphorylation mimic FMNL2N (S171DD) localized similarly well to the plasma membrane (Fig. 5a and Supplementary Fig. 6a, i and ii). This observation is not supporting the hypothesis that phosphorylation of S171 could be a release mechanism for FMNL2 membrane dissociation, as reported, for example, for myristoylated MARCKS proteins42. Mutation of all 12 basic residues in the insert helices to alanine (12A) reduced membrane association significantly, but not as potently as the myristoylation-defective G2A mutant (iii and iv). Only combined mutation of both membrane targeting motifs (G2A and 12A) resulted in fully cytosolic protein localization, establishing the cooperation of both motifs in membrane targeting of FMNL2 (v). Deletion of the flexible loop together with the second basic insert helix (Δ144–218, Δloop) reduced membrane localization only weakly. Yet, the defect was increased on combination with a deletion of the first basic insert helix (Δ93–100, Δ144–218, ΔΔloop) (vi and vii). The combination of the basic insert deletions with myristoylation deficiency (G2A+ΔΔloop) decreased membrane association even further (viii). Membrane localization of FMNL2N (G2A) in B16-F1 cells was significantly increased on co-transfection with constitutively active Cdc42(Q61L) (ix). In contrast, membrane association of the basic patch mutant FMNL2N 12A was reduced even further on co-expression of Cdc42(Q61L) (x). These observations suggest that a precast conformation of FMNL2N at the membrane mediated by the large basic surface patch supports a productive interaction with Cdc42. A quantification of the FMNL2 membrane binding features according to the evaluation scheme shown in Supplementary Fig. 7 is provided in Fig. 5b. The various protein constructs used are displayed in Supplementary Fig. 8. Co-sedimentation and PIP-strip assays of the FMNL2 N-terminal domains confirmed the membrane association in vitro, showing that the association is driven by myristoylation and electrostatic interaction (Supplementary Fig. 9).
FMNL1–Cdc42 assembles into a symmetrical dimer
Diaphanous-related formins Dia, Daam and FMNL, but not FHOD, contain dimerization elements following the regulatory GBD-FH3 domains4. This dimerization element comprises either a three helical bundle, designated as dimerization domain (DD) as found in mDia1 (refs 17, 18), or a coiled coil domain directly following the armadillo repeats. We succeeded in crystallizing the complex of Cdc42GppNHp with FMNL1NCC (1–458, Δ172–198), the last canonical armadillo repeat of which ends at position 380 (Fig. 6a). The complex was refined to 3.8 Å resolution (Table 1), allowing information on the overall assembly of the four subunits and the formation of the coiled coil backbone (Fig. 6b). The interaction network including the specific interactions of the insert helix seen for the FMNL2–Cdc42 complex are similarly observed in the FMNL1–Cdc42 structure, which is reflected by an root mean square deviation value of 0.63 Å over the aligned amino acids (Supplementary Fig. 10a).
Surprisingly, the FMNL1 FH3 structure is directly continuing into a parallel coiled coil segment starting at position 384, which could be resolved up to position 422 (Fig. 6b). The mostly hydrophobic dimer interface of the FH3 domain is essentially formed by two phenylalanines and one tyrosine as seen in the electron density map (Supplementary Fig. 10b). These residues are located on the first helix α17 of the fifth armadillo repeat and supported by neighbouring residues (Fig. 6c,d). The typical knobs-into-holes packing of the coiled coil assembly starts with its first amino acid V384 and is continued in the classical abcdefg hepta-repeat scheme, with residues at position a and d forming key interactions of the coiled coil43. An overview of the symmetric interaction pattern of the FMNL1 homodimer is shown in Fig. 6e. Although the crystal structure of the coiled coil domain is only resolved for the N-terminal 60% of this segment, its continuation can be anticipated from a sequence analysis up to the beginning of the proline-rich FH1 domain (Supplementary Fig. 11a,b). Analysis of the hepta-repeat structure suggests that the coiled coil element is interrupted by discontinuities, known as 'stammer' and 'stutter' motifs43. Such variations from the canonical hepta-repeat sequence by insertions of three and four residues, respectively, are known for many coiled coil containing proteins, as for example, myosin, possibly allowing proper folding of the domain and some conformational flexibility. The coiled coil element encompasses 101 amino acids in FMNL2 and FMNL3, spanning ∼152 Å in length, as derived from a modelling approach based on coiled coil elements containing similar stutter and stammer elements. In contrast, the coiled coil domain of FMNL1 contains only an ∼70 residues and misses the third segment but contains an elongated poly-proline FH1 region instead (Supplementary Fig. 11a,b).
The membrane targeting motifs align on a convex surface
The elongated conformation of the FMNL1 dimer was confirmed by size exclusion chromatography experiments showing an increase from 44 kDa in apparent mass for FMNL1N 2–385 to >200 kDa for FMNL1NCC 1–458 (Fig. 7a). This size was increased further on addition of triphosphate-bound Cdc42 to the complex, in agreement with binding of Cdc42 to the oppositely positioned formin GBD. This 'dimer of heterodimers' assembly leads to an umbrella-shaped structure of the FMNL1NCC–Cdc42 complex that is about 153 Å in width and 210 Å in height, based on modelling of the entire coiled coil segment, with an ∼50 Å in depth (Fig. 7b). A similar increase in size indicating protein dimerization was observed for the N-terminal FMNL2 constructs on inclusion of the coiled coil domain into the expression constructs (Supplementary Fig. 11c).
Binding of Cdc42 to the FMNL1 dimer leads to formation of a convex surface that contains the membrane interaction motifs (Fig. 6b). The position of the membrane interaction motifs in FMNL2 on activation by the GTPase can be localized based on the FMNL1NCC–Cdc42 complex structure. Strikingly, the N-terminal myristoylation site of FMNL2, the C-terminal geranylgeranyl moiety of Cdc42 and the 12 residues encompassing a polybasic patch all align on the convex surface of the heterodimer, leading in total to 6 symmetrically arranged membrane interaction motifs in the N-terminal domains of the activated formin complex (Fig. 7b). This assembly of the overall structure could support actin-based protrusions by orienting the formin appropriately towards the membrane and forming an outward membrane bulge for lamellipodia and filopodia growth (Fig. 7c).
Discussion
In this study, we show that the binding interface of the GTPase Cdc42 to its effector proteins FMNL1 and FMNL2 covers all five armadillo repeats of the formin in addition to the N-terminal GBD. Particularly, the Rho-GTPase-specific insert helix α4 of Cdc42 is involved in interactions with the fourth and fifth armadillo repeat of FMNL2, contributing thereby to the specificity of the formin recognition. While residues in the switch I and II regions of Rho GTPases are largely conserved within this GTPase family, amino acid changes occur among the four residues in the insert helix α4 that we identified here to contribute to effector binding. This is different from observations in the Ras-family of GTPases, where single amino acid changes in the switch regions (namely the 'effector loop' switch I) account for the specificity in signal transduction pathways by their defined interactions with downstream effector proteins44. Based on this interaction scheme, the specificity of Rho, Rac and Cdc42 GTPases for their effector proteins and thereby for distinct actin cytoskeleton phenotypes45 has remained unanswered. One recent example is the binding of the inverted BAR protein IRSp53 by its CRIB domain to Cdc42, where a proline-rich sequence following the CRIB domain interacts with a surface patch adjacent to the switch regions46. With the structures of the Cdc42–FMNL1 and -2 complexes determined here we attribute the insert helix of Rho GTPases a determining function in the recognition of formin effectors and propose to consider the entire GBD-FH3 domain assembly of DRFs as the full binding unit for Rho GTPases.
It has previously been shown that wild-type Rac1 was unable to interact with FMNL formins28. By transferring three residues from Cdc42 to Rac1, we were able to generate a gain-of-function mutation in Rac1 for FMNL2 binding and activation (Fig. 3). Mutation of A95E in the Rho-characteristic bulge of helix α3 and mutation of two variable amino acids in the insert helix of Rac1 (E131K and K132N) converted this triple mutant into a bona fide FMNL2 activator, both in vivo and in vitro. This 'proof-of-principle' experiment establishes that residues outside the canonical switch I and II regions can determine the specificity of Rho GTPases for their effector proteins. While we follow here a structure-based approach to change the effector-binding specificity of a Rho-GTPase, a heuristic algorithm was previously proposed for switch-of-function mutants in Rho family GTPases, based on the classification of cell morphologies47.
A conformational change in the switch regions of the GTPase on activation from the GDP- to GTP-bound state is a prerequisite for effector binding. These changes are recognized by the N-terminal GBD subdomain of the formin, particularly through interactions of its second helix with switch II of the GTPase. The distant armadillo repeats instead form ionic interactions with polar residues at the C terminus of the Cdc42 insert helix, contributing thus to an entire network of polar interactions in the interface of the two proteins. This mode of complex formation involving all armadillo repeats in conjunction with the GBD is likely to exist in all Rho-GTPase–formin interactions. The interaction might have previously not appeared due to crystal packing arrangements. The missing contribution of the C-terminal armadillo repeats to the specificity of the GTPase–formin interaction may indeed account for ambiguities of the effector-binding specificity in previous studies that were based on shortened domain fragmentations. To our knowledge, this is the first description of an involvement of the Rho-specific insert helix in binding and recognition of a downstream effector. An overview of binding interfaces of GDIs, GEFs, GAPs and effector proteins derived from different Rho GTPases is displayed in Supplementary Fig. 12.
FMNL2 is effectively targeted to lipid membranes by two membrane interacting motifs. While myristoylation is recognized from the primary sequence as an inherent N-terminal lipidation signal that occurs on protein translation, the surface patch composed of 12 positively charged residues in the FH3 domain of FMNL2 was only identified here on its structure determination. Myristoylation is often accompanied by amphipathic helices or adjacent cysteine palmitoylation motifs that strengthen the membrane association or may allow for reversible S-acylation cycles, respectively. Such additional motifs are not present in FMNL2 or FMNL3, as neither an accumulation of basic residues nor a cysteine is contained in the N-terminal sequence. Systematic analysis of the membrane interacting features of FMNL2 revealed that membrane binding decreases most significantly in the myristoylation-defective G2A mutant, whereas deletion of the polybasic patch results in a milder membrane association defect in cells (Fig. 5). Yet, while myristoylation sticks an acyl chain into the lipid membrane, the spacious basic surface patch in the FH3 domain of FMNL2 might help to orient the formin at the membrane leaflet. A precast orientation could facilitate the interaction with the GTPase at the membrane, which could in turn explain why active Cdc42 is able to fully restore membrane association of myristoylation-deficient FMNL2, whereas the polybasic FMNL2 12A mutant is not as effectively recruited to the membrane by the GTPase. We could, however, not find any indication for a myristoylation switch mechanism in FMNL2 on interaction with Cdc42. Such mechanism would imply that the myristate becomes exposed for insertion into the membrane only when it is displaced from a binding site on the formin, for example, on activation by the GTPase. This notion is consistent with the observation that FMNL2 is also capable of targeting the cell periphery in Cdc42-deficient cells28.
Among the four mammalian DRF families Dia, Daam, FMNL and FHOD, FMNL2 and FMNL3 are the only two orthologues that contain lipidation motifs, indicating their fate for membrane association. DRFs are activated by Rho GTPases that are C-terminally prenylated by either farnesylation or geranylgeranylation. The GTPases in turn become activated by guanine nucleotide exchange factors at specific membrane compartments, thus directing the formin to subcellular locations on activation. On binding and activation of FMNL2, Cdc42 contributes a potent third membrane targeting motif to the active formin–GTPase complex. As FMNL2 contains itself two membrane association motifs it is tempting to speculate that robust and stable membrane association is intimately linked to its function in lamellipodia and filopodia formation (Supplementary Fig. 13). The proposed forces exerted on formins while elongating actin filaments48 may indeed require a tight membrane association, mediated for FMNL2–Cdc42 by three targeting motifs that are spread over the surface of the protein complex. A model of active, membrane-bound FMNL2 on actin elongation is shown in Supplementary Fig. 14.
FMNL1 assembles into a symmetrical homodimer by its coiled coil domain following directly the armadillo repeats of the FH3 domain. The parallel long coiled coil region forms a second dimerization unit aside from the C-terminal head-to-tail dimer of the actin-polymerizing FH2 domain49. The long coiled coil element encompasses ∼70 residues in FMNL1 and about 100 residues in FMNL2 and FMNL3. It is interrupted by stammer and stutter elements of three and four residues, respectively, as known, for example, from myosins. These discontinuities might help folding the repetitive hepta-repeat chain into the precise periodic structure and add some flexibility to the rigid chains. The dimer interface is complemented by a homomeric assembly of the last armadillo repeat, suggesting a fixed arrangement of the two opposing FH3 domains. The Cdc42-bound FMNL complex thus assembles into an umbrella-shaped structure with a convex protein surface that harbours the three membrane binding sites of each heterodimer and an extended coiled coil element that might function as a place holder.
From the spacious conformation of the dimeric, N-terminal FMNL1NCC domain assembly (Fig. 7), it is difficult to envision how in the autoinhibited state the very C-terminal DAD interacts with the FH3 domain, considering the extended coiled coil element in between these two domains. Full-length, recombinant FMNL1 protein expressed from insect cells behaves as a dimer in size exclusion chromatography experiments (data not shown). At the plasma membrane, however, the FH2 domains, for example, of FMNL2, could dimerize with other FMNL2 dimers, thereby forming homogeneous, large clusters of this protein. Interestingly, supramolecular polymer structures have previously been described for other actin assembly machines, dependent on multivalent protein interactions, such as in the phospho-nephrin–Nck–N-WASP signalling module operating in Arp2/3 complex activation50. Multimer assemblies of FMNL2 dimers that associate by the coiled coil domain in cis- and by the FH2 domain in trans-configuration might generate the critical concentration of formin proteins required for effectively promoting filopodial and lamellipodial protrusions. Future studies will be designed to probe the effect of FMNL2 clustering at the membrane and curvature shaping for membrane outgrowth.
Methods
Plasmid cloning, protein expression and purification
The coding sequences of the N-terminal regions of human FMNL1 (isoform 1) and human FMNL2 (isoform 2), UniProt accession numbers O95466 and Q96PY5, were amplified from the full-length genes with primers containing NcoI and EcoRI restriction sites at the 5′ and 3′ ends, respectively. For FMNL1 protein expression constructs, a synthetic complementary DNA codon optimized for expression in insect cells (GeneArt, Regensburg) was used. FMNL1, FMNL2 and Rho-GTPase constructs were cloned in a pGEX-4T1 prokaryotic expression vector (GE Healthcare) modified with a tobacco etch virus protease cleavage site. Site-directed mutagenesis of FMNL2 and several Rac1 variants was performed using the mega primer method. All plasmids were confirmed by DNA sequencing prior to protein production.
Proteins were expressed in bacterial strains BL21-CodonPlus(DE3)-RIL, Rosetta(DE3) or B834 and purified as described, with certain modifications28. Briefly, plasmids encoding the desired N-terminal glutathione S-transferase (GST)-fusion constructs were transformed in Rosetta (DE3) cells and expressed at 293 K for 16 h using the overnight auto-induction expression method. Cells were harvested in lysis buffer (20 mM Tris/HCl pH 8.0, 500 mM NaCl, 10% glycerol, 1 mM dithioerythritol (DTE)) and lysed using a microfluidizer. Fusion proteins were isolated with GSH Sepharose FastFlow (GE Healthcare) affinity chromatography methods. The GST-tag was cleaved off with tobacco etch virus protease and separated from the desired proteins by gel filtration runs. FMNL1 proteins 1–385, 1–458, 1–458 (Δ172–198), and FMNL2 proteins 1–379, 1–379 (S171DD) and 1–489 were aliquoted in storage buffer, snap frozen in liquid nitrogen and stored at 193 K. Constructs corresponding to FMNL2 1–379 and FMNL1 1–458 were termed FMNL2N and FMNL1NCC, respectively. Protein homogeneities and identities were confirmed by analytical gel filtration analysis, SDS–PAGE experiments and electrospray ionization mass spectrometry. Selenomethionine-labelled proteins were expressed in B834 cells using the methionine biosynthesis inhibition method and purified as described above in buffers containing 5 mM DTE.
Rho GTPases were expressed in Escherichia coli cells as GST-fusion proteins without the C-terminal hypervariable region, and purified as described followed by nucleotide exchange for the non-hydrolysable GTP analogue GppNHp51. Reverse-phase C18 HPLC column was used for monitoring nucleotide loading status of the GTPases.
Complex formation and crystallization
The low affinity of interactions of active Cdc42 with N-terminal FMNL1 or FMNL2 fragments did not allow complex formation following co-purification strategies. Therefore, complex formations were carried out by equimolar mixing of N-terminal FMNL1 (1–458, Δ172–198) or FMNL2 (1–379) fragments with GppNHp-loaded Cdc42 (1–179) in high salt buffer (20 mM Tris/HCl pH 8.0, 500 mM NaCl, 5 mM MgCl2 and 1 mM DTE) followed by an overnight dialysis at 277 K in buffer C (20 mM Tris/HCl pH 8.0, 150 mM NaCl, 5 mM MgCl2 and 1 mM DTE). For crystallization experiments, the protein solutions were concentrated to 15 mg ml−1 (FMNL2N/Cdc42GppNHp) and 30 mg ml−1 (FMNL1NCC(Δ172–198)–Cdc42GppNHp).
Crystals of FMNL2N–Cdc42GppNHp were obtained in conditions consisting of 20 mM Tris/HCl (pH 8.0), 14% (v/v) PEG 3350 and 0.25 M magnesium acetate (FMNL2N–Cdc42) using the hanging drop vapour diffusion method at 293 K. The FMNL1NCC(Δ172–198)–Cdc42GppNHp complex crystallized in 17% (v/v) PEG 3350 and 0.16 M tri-ammonium citrate (FMNL1NCC–Cdc42). Crystals of SeMet-substituted FMNL2N in complex with native Cdc42 were obtained essentially as described for the native protein complex, but in reservoir solution with 5 mM DTE. For cryo-protection, single crystals grown to a size of 160 × 150 × 100 μm (FMNL2N–Cdc42) and 80 × 80 × 20 μM (FMNL1NCC–Cdc42) were transferred into a solution containing the mother liquor components and additional 20% ethylene glycol as cryo-protectant. After an incubation period of 30 s, crystals were flash cooled in liquid nitrogen.
Data collection and processing
Native diffraction data of the FMNL2N–Cdc42GppNHp complex were collected at 2.5 Å at cryogenic temperature (100 K) and data sets of the selenomethionin-labelled complex were collected at 3.5 Å. Crystals of the dimeric FMNL1NCC(Δ172-198)–Cdc42GppNHp complex diffracted up to 3.8 Å. All data sets were recorded with a MAR 225 CCD detector at X06SA beamline of the Swiss Light Source (SLS, Paul Scherrer Institute, Villigen, Switzerland) and processed with the XDS package52. Data collection and refinement statistics are summarized in Table 1.
Structure determination and refinement
The structure of FMNL2N–Cdc42GppNHp was solved by phase combination of a native data set and single-wavelength anomalous diffraction data collected at the selenium absorption edge. For the native complex structure, maximum likelihood molecular replacement was performed with Phaser from the CCP4 package53 using Cdc42 of the mDia1TSH–Cdc42GppNHp structure (PDB 3EG5, Chain A) as search model. Nine out of 12 selenium sites in FMNL2N were found in the data set of SeMet-labelled FMNL2N–Cdc42. Phase combination was carried out using Phaser-EP/Phenix54. The output file was merged with the native and SeMet-labelled data set and the initial phases were extended to the higher-resolution native data set in DM (CCP4; ref. 55). The structural model of FMNL2N–Cdc42 was manually built into the resulting electron density map using COOT56, and ligands (GppNHp, Mg2+) were also added manually. The resulting model was refined in REFMAC5 of the CCP4 programme suite57 and in Phenix.refine54. The solved FMNL2N–Cdc42 structure was taken as a search model for molecular replacement in Phaser (CCP4; ref. 53) to obtain an initial model of the dimeric FMNL1NCC(Δ172–198)–Cdc42GppNHp complex structure. This structure was refined using REFMAC5, Phenix.refine with the TLS, as well as NCS option and COOT. Ramachandran statistics for FMNL2N–Cdc42GppNHp and FMNL1NCC–Cdc42GppNHp confirmed geometries of all residues in the favoured region, with no outliers. Protein interfaces were calculated in PDBePISA58. All protein representations were created using the PyMOL software (DeLano Scientific LLC).
Isothermal titration calorimetry
Interactions of FMNL proteins with the GTPases Cdc42 (aa 1–179), Rac1 (aa 1–177) and Rac1 mutants or RhoA (aa 1–193) were performed by ITC using a MicroCal iTC200 microcalorimeter (GE Healthcare) as described59. Measurements were carried out in 20 mM Tris/HCl buffer (pH 8), 150 mM NaCl, 5 mM MgCl2, 1 mM DTE at 298 K. GTPases at a concentration of 500 μM were stepwise injected from the syringe to 50 μM FMNL placed in the measurement cell. The change in heating power was observed over the reaction time until equilibrium was reached. Data were analysed using the software provided by the manufacturer.
Size exclusion chromatography
Analytical gel filtrations of FMNL1, FMNL2 and Cdc42 proteins were performed using a multicomponent Waters 626 LC system (Waters, MA) equipped with a Superdex S200 (10/300 GL) column (GE Healthcare). Typically, 100 μg of each protein were loaded onto the column that was equilibrated in 20 mM Tris/HCl (pH 8.0), 150 mM NaCl, 1 mM DTE buffer (supplemented with 2.5 mM MgCl2 in the presence of Rho GTPases) prior to injection of the protein samples. Gel filtrations were run at a flow rate of 0.5 ml min−1 at 293 K. The optical density was monitored at a wavelength of 280 nm over the time course of the experiment. Gel filtration experiments were performed repeatedly.
In vitro GST pull-down experiments
For pull-down assays, glutathione–sepharose beads (GE Healthcare) were loaded with the respective GST-tagged Rho-GTPase and washed two times in binding buffer (20 mM Tris/HCl pH 8.0, 150 mM NaCl, 10% glycerol, 0.005% Triton X-100 and 1 mM β-mercaptoethanol). Afterwards, the GTPase-bound beads were incubated with equal amounts of FMNL1NCC in 275 μl binding buffer for 30 min at 277 K and washed three times with 250 μl binding buffer. The beads were resuspended in 20 μl SDS loading buffer and interactions were analysed by SDS–PAGE analysis (8 μl of each sample loaded on an 18% SDS–PAGE gel). Pull-down experiments shown in Supplementary Fig. 5 using a rabbit Sra-1 antibody (Sra-1B) were carried out as described60. The rabbit N-WASP antibody (N-WASP-crib1 8593) was raised against a synthetic peptide comprising aa 193–212.
Mammalian expression constructs and cell transfections
Full-length EGFP–FMNL2 and FMNL2–EGFP capable of N-terminal myristoylation were described in ref. 28. Fusions of EGFP with N-terminal fragments of FMNL2 (aa 1–385 and mutants thereof) were generated using restriction sites EcoRI and KpnI in pEGFP–N1 expression vector (Clontech Laboratories, Mountain View, USA) harbouring a monomeric variant of EGFP, allowing for eukaryotic expression of myristoylated, FMNL2N–mEGFP fusion proteins. FMNL2N mutations G2A, S171DD, the 12-mer mutation R93, K94, K95, R97, R98, R99, R206, R207, K210, R213, K217 and K218 all to alanine, the loop deletion mutations Δ144–218 and Δ93–100 and combinations thereof were cloned with the mega primer method. Myc-Rac1 (L61, E95, K131 and N132) was subcloned from pGEX-2T using BamHI and EcoRI and ligated into pRK5myc. All coding plasmids were confirmed by DNA sequencing prior to transfection.
B16-F1 mouse melanoma cells were grown and transfected with Superfect (Qiagen) essentially as described61,28 or transfected with PeqFect (Peqlab, Germany) according to the manufacturer’s instructions using 0.5 μg DNA and 1 μl PeqFect. B16-F1 cells were transiently transfected with expression constructs overnight and seeded on glass coverslips or WillCo wells (Amsterdam, The Netherlands) coated with laminin (Roche; 25 μg ml−1). Widefield microscopy was performed on cells on coverslips in an open heating chamber (Warner Instruments, Hamden, CT, USA) with heater controller (Model TC-324 B, SN 1176) at 37 °C. Cells were maintained in microscopy medium (HAM’s F12 HEPES-buffered medium, Sigma-Aldrich Co.) including complete supplements.
Fluorescence microscopy
Images from live cells shown in Fig. 5 were recorded using a spinning disc confocal microscope. Images were taken using a Nikon Eclipse Ti microscope equipped with a spinning disc confocal device (UltraVIEW VoX; Perkin Elmer), solid state 488 nm laser (Modular Laser System 2.0, Perkin Elmer), a Hamamatsu EM-CCD camera (C9100-50, Hamamatsu) and a Nikon 60 × /1.4 numerical aperture Apo objective steered by Volocity software. Cells were maintained in a climate chamber using microscopy medium.
Live-cell imaging shown in Supplementary Fig. 6 was performed with phase-contrast and widefield fluorescence optics as described28, using a 63 × /1.4 numerical aperture Plan Neofluar objective. For comparing localization of full-length FMNL2 capable of N-terminal myristolation with actin networks and bundles, B16-F1 cells transiently expressing FMNL2–EGFP and plated on laminin were fixed with 4% paraformaldehyde in phosphate-buffered saline (20 min) followed by brief extraction (1 min) with 0.1% Triton X-100 and counterstaining with Alexa594-conjugated phalloidin (Life Technologies). Samples were subjected to fluorescence microscopy as described28, and green and red fluorescence channels recorded separately and merged.
Two alternative and complementary methods were developed to quantify relative plasma membrane associations of FMNL2 N-terminal constructs, one based on confocal and the second based on widefield imaging. In case of confocal imaging shown in Fig. 5, the procedure was as follows. To distinguish between plasma membrane-associated and cytosolic protein, two different planes of each cell were recorded, one focusing on the substratum and the second 2 μm above this plane (see Supplementary Fig. 7a). Fluorescence in flat cellular regions of substrate plane images mostly reflects signals from plasma membrane-associated EGFP-tagged constructs, whereas fluorescence from a region 2 μm above the substrate plane between nucleus and plasma membrane was defined to correspond to the cytosolic region. Corresponding circular regions that were measured in each part of confocal plane using Volocity software are indicated in Fig. 5. Relative intensities were expressed as ratios of ‘plasma membrane region’ and ‘cytosolic region’. Twelve or more cells were measured for each construct and averaged. For the wild-type N terminus of FMNL2, which is membrane associated, this ratio was 1.53 and normalized to 1.0. The lowest measured ratio (0.21) was obtained for mutant G2A 12A protein and set to 0 in the bar chart in Fig. 5b, to ease readability of the figure and comparison of values derived from various constructs.
Quantitation of the widefield images shown in Supplementary Fig. 6 was based on the following considerations. Fluorescence intensity of cytosolic proteins when imaged by widefield optics largely depends on cell thickness, whereas this does not hold true for factors exclusively associated with the plasma membrane. More specifically, plasma membrane-associated signals generate cell images with homogenously distributed fluorescence intensity (for example, see signal distribution of plasma membrane-associated FMNL2N in Supplementary Fig. 6a, i). Images were recorded and processed using Metamorph software (Molecular Devices). To quantify the data, we divided average fluorescence intensity in the lamella, which constitutes the very flat region at the cell periphery behind ruffling lamellipodia by average intensity of the entire cell (see also Supplementary Fig. 7b). Highest and lowest ratios were normalized to 1.0 and 0, respectively.
Additional information
Accession codes: Atomic coordinates and structure factor files of the FMNL2N–Cdc42GppNHp and FMNL1NCC–Cdc42GppNHp complex structures have been deposited in the Protein Data Bank under accession codes 4YC7 and 4YDH, respectively.
How to cite this article: Kühn, S. et al. The structure of FMNL2–Cdc42 yields insights into the mechanism of lamellipodia and filopodia formation. Nat. Commun. 6:7088 doi: 10.1038/ncomms8088 (2015).
References
Blanchoin, L., Boujemaa-Paterski, R., Sykes, C. & Plastino, J. Actin dynamics, architecture, and mechanics in cell motility. Physiol. Rev. 94, 235–263 (2014).
Campellone, K. G. & Welch, M. D. A nucleator arms race: cellular control of actin assembly. Nat. Rev. Mol. Cell Biol. 11, 237–251 (2010).
Chesarone, M. A., DuPage, A. G. & Goode, B. L. Unleashing formins to remodel the actin and microtubule cytoskeletons. Nat. Rev. Mol. Cell Biol. 11, 62–74 (2010).
Schönichen, A. & Geyer, M. Fifteen formins for an actin filament: a molecular view on the regulation of human formins. Biochim. Biophys. Acta 1803, 152–163 (2010).
Otomo, T. et al. Structural basis of actin filament nucleation and processive capping by a formin homology 2 domain. Nature 433, 488–494 (2005).
Goode, B. L. & Eck, M. J. Mechanism and function of formins in the control of actin assembly. Annu. Rev. Biochem. 76, 593–627 (2007).
Romero, S. et al. Formin is a processive motor that requires profilin to accelerate actin assembly and associated ATP hydrolysis. Cell 119, 419–429 (2004).
Kovar, D. R., Harris, E. S., Mahaffy, R., Higgs, H. N. & Pollard, T. D. Control of the assembly of ATP- and ADP-actin by formins and profilin. Cell 124, 423–435 (2006).
Gould, C. J. et al. The formin DAD domain plays dual roles in autoinhibition and actin nucleation. Curr. Biol. 21, 384–390 (2011).
Heimsath, E. G. Jr & Higgs, H. N. The C terminus of formin FMNL3 accelerates actin polymerization and contains a WH2 domain-like sequence that binds both monomers and filament barbed ends. J. Biol. Chem. 287, 3087–3098 (2012).
Ramabhadran, V., Hatch, A. L. & Higgs, H. N. Actin monomers activate inverted formin 2 by competing with its autoinhibitory interaction. J. Biol. Chem. 288, 26847–26855 (2013).
Pruyne, D. et al. Role of formins in actin assembly: nucleation and barbed-end association. Science 297, 612–615 (2002).
Sagot, I., Rodal, A. A., Moseley, J., Goode, B. L. & Pellman, D. An actin nucleation mechanism mediated by Bni1 and profilin. Nat. Cell Biol. 4, 626–631 (2002).
Li, F. & Higgs, H. N. The mouse Formin mDia1 is a potent actin nucleation factor regulated by autoinhibition. Curr. Biol. 13, 1335–1340 (2003).
Schönichen, A. et al. FHOD1 is a combined actin filament capping and bundling factor that selectively associates with actin arcs and stress fibres. J. Cell Sci. 126, 1891–1901 (2013).
Watanabe, N., Kato, T., Fujita, A., Ishizaki, T. & Narumiya, S. Cooperation between mDia1 and ROCK in Rho-induced actin reorganization. Nat. Cell Biol. 1, 136–143 (1999).
Rose, R. et al. Structural and mechanistic insights into the interaction between Rho and mammalian Dia. Nature 435, 513–518 (2005).
Otomo, T., Otomo, C., Tomchick, D. R., Machius, M. & Rosen, M. K. Structural basis of Rho GTPase-mediated activation of the formin mDia1. Mol. Cell 18, 273–281 (2005).
Etienne-Manneville, S. & Hall, A. Rho GTPases in cell biology. Nature 420, 629–635 (2002).
Nobes, C. D. & Hall, A. Rho, Rac, and Cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibres, lamellipodia, and filopodia. Cell 81, 53–62 (1995).
Lammers, M., Meyer, S., Kühlmann, D. & Wittinghofer, A. Specificity of interactions between mDia isoforms and Rho proteins. J. Biol. Chem. 283, 35236–35246 (2008).
Kühn, S. & Geyer, M. Formins as effector proteins of Rho GTPases. Small GTPases 5, e29513 (2014).
Yayoshi-Yamamoto, S., Taniuchi, I. & Watanabe, T. FRL, a novel formin-related protein, binds to Rac and regulates cell motility and survival of macrophages. Mol. Cell Biol. 20, 6872–6881 (2000).
Harris, E. S., Li, F. & Higgs, H. N. The mouse formin, FRLalpha, slows actin filament barbed end elongation, competes with capping protein, accelerates polymerization from monomers, and severs filaments. J. Biol. Chem. 279, 20076–20087 (2004).
Harris, E. S., Gauvin, T. J., Heimsath, E. G. & Higgs, H. N. Assembly of filopodia by the formin FRL2 (FMNL3). Cytoskeleton 67, 755–772 (2010).
Esue, O., Harris, E. S., Higgs, H. N. & Wirtz, D. The filamentous actin cross-linking/bundling activity of mammalian formins. J. Mol. Biol. 384, 324–334 (2008).
Vaillant, D. C. et al. Interaction of the N- and C-terminal autoregulatory domains of FRL2 does not inhibit FRL2 activity. J. Biol. Chem. 283, 3750–3762 (2008).
Block, J. et al. FMNL2 drives actin-based protrusion and migration downstream of Cdc42. Curr. Biol. 22, 1005–1012 (2012).
Favaro, P. M. et al. Human leukocyte formin: a novel protein expressed in lymphoid malignancies and associated with Akt. Biochem. Biophys. Res. Commun. 311, 365–371 (2003).
Favaro, P. M. et al. High expression of FMNL1 protein in T non-Hodgkin's lymphomas. Leuk. Res. 30, 735–738 (2006).
Zhu, X. L. et al. FMNL2 is a positive regulator of cell motility and metastasis in colorectal carcinoma. J. Pathol. 224, 377–388 (2011).
Kitzing, T. M., Wang, Y., Pertz, O., Copeland, J. W. & Grosse, R. Formin-like 2 drives amoeboid invasive cell motility downstream of RhoC. Oncogene 29, 2441–2448 (2010).
Gomez, T. S. et al. Formins regulate the actin-related protein 2/3 complex-independent polarization of the centrosome to the immunological synapse. Immunity 26, 177–190 (2007).
Seth, A., Otomo, C. & Rosen, M. K. Autoinhibition regulates cellular localization and actin assembly activity of the diaphanous-related formins FRLalpha and mDia1. J. Cell Biol. 174, 701–713 (2006).
Gardberg, M. et al. Characterization of Diaphanous-related formin FMNL2 in human tissues. BMC Cell Biol. 11, 55 (2010).
Zhu, X. L., Liang, L. & Ding, Y. Q. Overexpression of FMNL2 is closely related to metastasis of colorectal cancer. Int. J. Colorectal. Dis. 23, 1041–1047 (2008).
Lybaek, H. et al. An 8.9Mb 19p13 duplication associated with precocious puberty and a sporadic 3.9Mb 2q23.3q24.1 deletion containing NR4A2 in mentally retarded members of a family with an intrachromosomal 19p-into-19q between-arm insertion. Eur. J. Hum. Genet. 17, 904–910 (2009).
Vega, F. M., Fruhwirth, G., Ng, T. & Ridley, A. J. RhoA and RhoC have distinct roles in migration and invasion by acting through different targets. J. Cell Biol. 193, 655–665 (2011).
Mason, F. M., Heimsath, E. G., Higgs, H. N. & Soderling, S. H. Bi-modal regulation of a formin by srGAP2. J. Biol. Chem. 286, 6577–6586 (2011).
Favaro, P. et al. FMNL1 promotes proliferation and migration of leukemia cells. J. Leukoc. Biol. 94, 503–512 (2013).
Olsen, J. V. et al. Global, in vivo, and site-specific phosphorylation dynamics in signalling networks. Cell 127, 635–648 (2006).
McLaughlin, S. & Aderem, A. The myristoyl-electrostatic switch: a modulator of reversible protein-membrane interactions. Trends Biochem. Sci. 20, 272–276 (1995).
Lupas, A. N. & Gruber, M. The structure of alpha-helical coiled coils. Adv. Protein Chem. 70, 37–78 (2005).
Herrmann, C. Ras-effector interactions: after one decade. Curr. Opin. Struct. Biol. 13, 122–129 (2003).
Ridley, A. J. & Hall, A. The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibres in response to growth factors. Cell 70, 389–399 (1992).
Kast, D. J. et al. Mechanism of IRSp53 inhibition and combinatorial activation by Cdc42 and downstream effectors. Nat. Struct. Mol. Biol. 21, 413–422 (2014).
Heo, W. D. & Meyer, T. Switch-of-function mutants based on morphology classification of Ras superfamily small GTPases. Cell 113, 315–328 (2003).
Fletcher, D. A. & Mullins, R. D. Cell mechanics and the cytoskeleton. Nature 463, 485–492 (2010).
Thompson, M. E., Heimsath, E. G., Gauvin, T. J., Higgs, H. N. & Kull, F. J. FMNL3 FH2-actin structure gives insight into formin-mediated actin nucleation and elongation. Nat. Struct. Mol. Biol. 20, 111–118 (2013).
Li, P. et al. Phase transitions in the assembly of multivalent signalling proteins. Nature 483, 336–340 (2012).
Schönichen, A. et al. Biochemical characterization of the diaphanous autoregulatory interaction in the formin homology protein FHOD1. J. Biol. Chem. 281, 5084–5093 (2006).
Kabsch, W. XDS. Acta Crystallogr. D Biol. Crystallogr 66, 125–132 (2010).
McCoy, A. J. et al. Phaser crystallographic software. J. Appl. Crystallogr 40, 658–674 (2007).
Adams, P. D. et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D Biol. Crystallogr. 66, 213–221 (2010).
Winn, M. D. et al. Overview of the CCP4 suite and current developments. Acta Crystallogr. D Biol. Crystallogr. 67, 235–242 (2011).
Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 60, 2126–2132 (2004).
Murshudov, G. N. et al. REFMAC5 for the refinement of macromolecular crystal structures. Acta Crystallogr. D Biol. Crystallogr. 67, 355–367 (2011).
Krissinel, E. & Henrick, K. Inference of macromolecular assemblies from crystalline state. J. Mol. Biol. 372, 774–797 (2007).
Schulte, A. et al. The human formin FHOD1 contains a bipartite structure of FH3 and GTPase-binding domains required for activation. Structure 16, 1313–1323 (2008).
Steffen, A. et al. Sra-1 and Nap1 link Rac to actin assembly driving lamellipodia formation. EMBO J. 23, 749–759 (2004).
Block, J. et al. Filopodia formation induced by active mDia2/Drf3. J. Microsc. 231, 506–517 (2008).
Acknowledgements
We thank Karin Vogel-Bachmayr and Gerd Landsberg for excellent technical assistance; André Schönichen for discussions; and Ingrid Vetter and Kanchan Anand for advice on crystal data analysis. M.G. and K.R. are members of the DFG priority program SPP 1464. This work was supported by grants from the Deutsche Forschungsgemeinschaft to M.G. (GE-976/7-1) and K.R. (RO-2414/3-1). M.G. is a member of the DFG Excellence Cluster ImmunoSensation. S.K. is a member of the IMPRS in Chemical Biology, Dortmund.
Author information
Authors and Affiliations
Contributions
S.K. expressed, purified and crystallized the proteins, collected the data and determined the crystal structures. F.K., J.B. and L.S. performed the cell biology experiments under the supervision of A.S. and K.R. For Rac1 mutant studies, S.K. and C.E. purified the proteins and performed in vitro binding experiments, and S.K. performed and analysed additional biochemical experiments. M.G. designed the study and wrote the manuscript together with S.K., A.S. and K.R. All authors discussed the results and commented on the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Information
Supplementary Figures 1-14 and Supplementary References (PDF 4634 kb)
Rights and permissions
This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
About this article
Cite this article
Kühn, S., Erdmann, C., Kage, F. et al. The structure of FMNL2–Cdc42 yields insights into the mechanism of lamellipodia and filopodia formation. Nat Commun 6, 7088 (2015). https://doi.org/10.1038/ncomms8088
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/ncomms8088
This article is cited by
-
Prioritization of putatively detrimental variants in euploid miscarriages
Scientific Reports (2022)
-
Proximity proteomics identifies PAK4 as a component of Afadin–Nectin junctions
Nature Communications (2021)
-
Assembly of a persistent apical actin network by the formin Frl/Fmnl tunes epithelial cell deformability
Nature Cell Biology (2020)
-
FMNL formins boost lamellipodial force generation
Nature Communications (2017)
-
FMNL2 and -3 regulate Golgi architecture and anterograde transport downstream of Cdc42
Scientific Reports (2017)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.